352 related articles for article (PubMed ID: 9882763)
21. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
22. Oral contraception in women with mild thrombophilia: what have we learned recently?
Blanco-Molina Á
Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
[TBL] [Abstract][Full Text] [Related]
23. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
24. Coagulation and thrombosis with OC use: physiology and clinical relevance.
Comp PC
Dialogues Contracept; 1996; 5(1):1-3. PubMed ID: 12347721
[TBL] [Abstract][Full Text] [Related]
25. Inherited thrombophilia and gestational venous thromboembolism.
Conard J; Horellou MH; Samama MM
Semin Thromb Hemost; 2003 Apr; 29(2):131-42. PubMed ID: 12709916
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism in women taking hormonal contraceptives.
Blanco-Molina A; Monreal M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
[TBL] [Abstract][Full Text] [Related]
27. The truth about oral contraceptives and venous thromboembolism.
Shulman LP; Goldzieher JW
J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
[TBL] [Abstract][Full Text] [Related]
28. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Odlind V; Milsom I; Persson I; Victor A
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
[TBL] [Abstract][Full Text] [Related]
29. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
[TBL] [Abstract][Full Text] [Related]
30. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium.
Nelson SM; Greer IA
Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918
[TBL] [Abstract][Full Text] [Related]
31. Screening for inherited thrombophilia: indications and therapeutic implications.
De Stefano V; Rossi E; Paciaroni K; Leone G
Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166
[TBL] [Abstract][Full Text] [Related]
32. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
Eichinger S
Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
34. Inherited thrombophilia and venous thromboembolism.
Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
[TBL] [Abstract][Full Text] [Related]
35. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
[TBL] [Abstract][Full Text] [Related]
37. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
38. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
Wu O; Robertson L; Twaddle S; Lowe G; Clark P; Walker I; Brenkel I; Greaves M; Langhorne P; Regan L; Greer I;
Br J Haematol; 2005 Oct; 131(1):80-90. PubMed ID: 16173967
[TBL] [Abstract][Full Text] [Related]
39. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
40. Screening for a prothrombotic diathesis in patients attending family planning clinics.
Kalev M; Day T; Van de Water N; Ockelford P
N Z Med J; 1999 Sep; 112(1096):358-61. PubMed ID: 10587055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
